Trial intelligence / Profile preview

Effects of ivabradine on cardiovascular events in chronic heart failure

2006-000708-18Phase 3Completed

Sponsor
Servier
Start
Aug 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD) comparing Ivabradine with Placebo (2 arms). Primary endpoint: Primary composite endpoint. Started Aug 2006; status: completed.

02

Drugs

ivabradine
03

Conditions

chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)

Beyond the preview

Go deeper on 2006-000708-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000708-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call